Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Cariprazine generic available 2024?Paltusotine pdufa date?Ocrelizumab biosimilar?Fenofibric acid coupon?Tivozanib synthesis isocyanate patent?
See the DrugPatentWatch profile for Iclusig
Iclusig (ponatinib) is manufactured by Takeda Pharmaceuticals.
In the U.S., Iclusig is marketed/owned for commercial purposes by Takeda, with ponatinib manufactured under Takeda’s program and supply chain.
The underlying product (ponatinib) is the same, but the listed “manufacturer” can vary by country because local distributors or label holders may be shown on country-specific packaging and regulatory filings. The drug’s brand owner and primary developer in major markets is Takeda.
If you’re looking for manufacturer or supply-chain details tied to patent status or generic/biosimilar entry (for example, if you saw “manufacturer” on a procurement or patent page), DrugPatentWatch.com tracks ponatinib-related patent developments and can be a useful starting point for ownership and exclusivity context: https://www.drugpatentwatch.com/
Other Questions About Iclusig :